Navigation Links
North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
Date:5/28/2013

Manhasset, NY (PRWEB) May 28, 2013

The 2013 Commencement Exercises for the Elmezzi Graduate School of Molecular Medicine and the Academic Convocation for the Hofstra North Shore-LIJ School of Medicine were held May 23 at The Feinstein Institute for Medical Research. Each year during this event, the Elmezzi Graduate School awards an honorary degree to an outstanding physician who has advanced biomedical research and improved medical treatment for patients. This year, Frederick W. Alt, PhD, from Harvard Medical School and Boston Children's Hospital, was recognized for his work in cancer and immunology.

During the commencement exercises for the Elmezzi Graduate School, students who have completed their dissertation studies are granted the degree of Doctor of Philosophy, Molecular Medicine. The Elmezzi Graduate School of Molecular Medicine is a PhD program for physicians who wish to pursue careers in biomedical education. During their training, Elmezzi students conduct research in Feinstein Institute laboratories to advance biomedical knowledge and to pursue new therapeutic approaches and diagnostic tools. This year, three graduate students received their degrees:

  •     Eitan Giat, MD, for his work in lupus. His thesis is entitled “The Inhibition of the Interferon Signature by the Dweus Peptide through Inactivation of HMGB1.”
  •     Ben Lu, MD, for his work in inflammation. His thesis is entitled “The Regulation of HMGB1 Release.”
  •     Sergio I. Valdes-Ferrer, MD, for his work in sepsis. His thesis is entitled “HMGB1 is a Key Mediator of Sustained Inflammation in Sepsis Survivors.”

The academic convocation for the Hofstra North Shore-LI
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New online portal, app provide information on tsunami zones in the Northwest
2. A North American first at the Montreal Heart Institute
3. Symtrex Inc. Signs Up with ImmuneSecurity to Launch LogInspect to the North American Market
4. Northwestern launches comprehensive program for patients with bicuspid aortic valve disease
5. Northwestern Medicine hosts the National Marfan Foundations Annual Conference
6. Northwestern researchers investigate treatment for tumor cells in spinal fluid
7. North Texas Cities to Start West Nile Spraying Thursday
8. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
9. Power Slowly Returns to Much of Northeast After Sandy
10. Kessler awarded $2 million federal grant for Northern NJ Traumatic Brain Injury System
11. Heart Health Worst in the South, Best in Northeast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/7/2014)... in fact hide clues that lung cancer will later ... The University of Texas MD Anderson Cancer Center The ... the National Cancer Institute . , Examination of gene ... showed the area adjacent to tumors is rich with ... role of a cancer-promoting gene in the airways of ...
(Date:3/7/2014)... contact lens could possibly make life easier for some of ... sneezing and a runny nose as soon as the pollen ... a newly developed Danish mini-filter - Rhinix - appears to ... fever than a filterless placebo., The study has just been ... Immunology . , Filter blocks pollen , The filter, ...
(Date:3/6/2014)... at the University of California, San Diego School of Medicine ... a history of Kawasaki disease (KD), concluding that the risks ... are published in the March 6, 2014 online edition of ... , KD is a childhood condition affecting the coronary arteries. ... in children. First recognized in Japan following World War II, ...
(Date:3/6/2014)... promoted as a way to quit regular cigarettes, may ... nicotine addiction for teenagers, according to a new UC ... the relationship between e-cigarette use and smoking among adolescents ... who used the devices were more likely to smoke ... of nearly 40,000 youth around the country also found ...
(Date:3/5/2014)... Frank Porter Graham Child Development Institute (FPG) and 6 ... after high school. , "Public high schools may be ... autismand for their families," said FPG director Samuel L. ... few social ties after school ends." , According to ... hard to achieve beneficial results for students with autism ...
Breaking Medicine News(10 mins):Health News:Cells appearing normal may actually be harbingers of lung cancer 2Health News:Cells appearing normal may actually be harbingers of lung cancer 3Health News:Danish nasal filter looks promising for allergy sufferers 2Health News:Kawasaki disease and pregnant women 2Health News:E-cigarettes: Gateway to nicotine addiction for US teens, says UCSF study 2Health News:E-cigarettes: Gateway to nicotine addiction for US teens, says UCSF study 3Health News:New program for students with autism offers hope after high school 2
... Aug. 31 During a campaign stop,in the Palmetto ... say how he would address America,s health care crisis, ... states to decide. [Associated Press,8/31/07] Yet, in the face ... overtime to distance himself from the Massachusetts,health care plan ...
... reduction over 6 weeks , , FRIDAY, Aug. 31 (HealthDay News) ... hot flashes of menopause, Mayo Clinic researchers report. , A ... who used dietary flaxseed daily reported a 50 percent reduction ... "Flaxseed worked very well," said Dr. Sandhya Pruthi, director of ...
... vital role in maintaining blood supply, WASHINGTON, Aug. ... difficult season for blood collection, and one that blood,centers ... tight blood,supplies since Memorial Day, there is relief in ... school blood drives. (PHOTO: http://www.newscom.com/cgi-bin/prnh/20070831/DCF008 ) ...
... MINNEAPOLIS, Aug. 31 HEI, Inc. (Nasdaq: ... has entered into an agreement,to sell substantially all ... Smartrac,Technology US, Inc., a wholly-owned subsidiary of Dutch ... sale of substantially all the assets of,the RFID ...
... 31 Landauer, Inc. (NYSE:,LDR) announced today that its ... $0.475 per share for the fourth quarter of,fiscal 2007. ... to shareholders,of record on September 14, 2007. About ... services to determine,occupational and environmental radiation exposure. For more ...
... MYL ) ("Mylan") announced today that it is ... of its outstanding 5.750% Senior Notes due,2010 (CUSIP No. ... 628530AC1) (collectively, the "Notes"). Mylan is making the ... its new global capital structure and in preparation for ...
Cached Medicine News:Health News:DNC: South Carolina Rejecting Romney's Smooth Talk on Health Care 2Health News:Flaxseed May Relieve Hot Flashes 2Health News:Back to School Means Return of School Blood Drives 2Health News:Back to School Means Return of School Blood Drives 3Health News:HEI, Inc. Announces Sale of RFID Division Assets 2Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 2Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 3Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 4
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014 /PRNewswire/ ... "Lifetime in Dermatology Achievement Award" from the Journal ... Orlando Dermatology Aesthetic & Clinical Conference (ODAC). The event ... in Florida . ... comprehensive report on the practice of dermatology for clinical ...
(Date:1/15/2014)... -- Tegra Medical is very pleased to announce the ... its new Chief Executive Officer.  Mark was promoted from ... he has overseen the company,s four facilities in ... and Costa Rica.  Mr. King joined Tegra Medical in ... and manufacturing experience in medical device businesses, both in ...
(Date:1/15/2014)... -- According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ... markets. The European radioembolization sphere market ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... of Cimzia® (certolizumab pegol; CZP) to current therapy ... function and reduced disease activity in a diverse ... those seen in daily clinical practice (including those ... data were presented during the American College of ...
... CryoLife, Inc. (NYSE: CRY ), an ... today that it will participate in the Lazard Capital Markets ... New York City. Steven G. Anderson, president and ... Tuesday, November 16, 2010 at 4:10 p.m., Eastern Time. ...
Cached Medicine Technology:New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 2New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 3New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 4New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 5New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 6New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 7New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 8New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 9New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA) 10CryoLife to Present at Lazard Capital Markets 7th Annual Healthcare Conference 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: